AbbVie to acquire a J&J-backed brain drugmaker for $1.4B

Buying Aliada Therapeutics would hand AbbVie a clinical-stage Alzheimer’s medicine and a drugmaking technology that may be useful for a variety of brain diseases.

Nigeria-Korea solar mini-grid project electrifies Abuja communities – EnviroNews

February 12, 2026

Sanofi, looking for more ‘rigor,’ swaps CEO Hudson for ex-Merck KGaA chief Garijo

February 12, 2026

Source link

AbbVie to acquire a J&J-backed brain drugmaker for $1.4B

Nigeria-Korea solar mini-grid project electrifies Abuja communities – EnviroNews

Sanofi, looking for more ‘rigor,’ swaps CEO Hudson for ex-Merck KGaA chief Garijo

‘It’s a hustle’: Fish market folk in Barbados experience more struggle since Hurricane Beryl

Responsible AI practices help companies create value

Responsible AI practices help companies create value

Leave a Reply Cancel reply

RECOMMENDED NEWS

Why do people experience poor cell phone signal?

The Real Cost of Franchising

Taking decarbonisation further with demand-side flexibility

Federal Government Takes Action to Reduce Housing Costs

POPULAR NEWS

Ghana to build three oil refineries, five petrochemical plants in energy sector overhaul

The world’s top 10 most valuable car brands in 2025

Top 10 African countries with the highest GDP per capita in 2025

Global ranking of Top 5 smartphone brands in Q3, 2024

When Will SHIB Reach $1? Here’s What ChatGPT Says

AbbVie to acquire a J&J-backed brain drugmaker for $1.4B

Related posts

‘It’s a hustle’: Fish market folk in Barbados experience more struggle since Hurricane Beryl

Responsible AI practices help companies create value

Leave a Reply Cancel reply

RECOMMENDED NEWS

POPULAR NEWS